Treatment Registry
TR-0503 ActiveRecorded September 2026

Compounded tirzepatide

Sold by Genesis Health · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$225

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Monthly Plan · recorded initial monthly payment$225

Added from the figures recorded below.

Price

TermPer monthCharged today
Monthly Plan

“Monthly Plan $225 billed monthly $225”

Per month$225Charged today$225
Quarterly Plan

“Quarterly Plan $565 billed every 3 months $188.33”

Per month$188.33Charged today$565
Annual Plan

“Annual Plan $1,500 billed annually $125”

Per month$125Charged today$1,500
Price sources
Visit Genesis Health

We earn nothing from this link. It opens Genesis Health's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberBoth
CancellationPlans are offered as a subscription and can be canceled at any time.

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from trygenesis.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Full 4-tier pricing (monthly/quarterly/bi-annual/annual) found on the dedicated product pages for both compounded semaglutide and compounded tirzepatide, all stated as all-inclusive (consultation, medication, coaching support). Also offers Ozempic, Wegovy, and Zepbound by name in the medications list, but with no separate branded pricing shown anywhere, so no branded entries were recorded. Neither product page states injection vial vs. pen.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0503
Medication category
compounded tirzepatide
Readings
1

Related records

Other records from Genesis Health

All Genesis Health programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Genesis Health — compounded tirzepatide (TR-0503). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0503

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.